• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院期间接受中心静脉置管的患者,住院时间可预测早期感染风险。

Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement.

作者信息

Tang Linnan, Kim Charles Y, Martin Jonathan G, Pabon-Ramos Waleska M, Sag Alan A, Suhocki Paul V, Smith Tony P, Ronald James

机构信息

Division of Vascular and Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710.

Division of Vascular and Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710.

出版信息

J Vasc Interv Radiol. 2020 Mar;31(3):454-461. doi: 10.1016/j.jvir.2019.10.017. Epub 2020 Jan 29.

DOI:10.1016/j.jvir.2019.10.017
PMID:32007408
Abstract

PURPOSE

To compare early totally implantable central venous port catheter-related infection rates after inpatient vs outpatient placement and to determine whether the risk associated with inpatient placement is influenced by length of hospital stay.

MATERIALS AND METHODS

In this single-institution retrospective study, 5,301 patients (3,618 women; mean age 57 y) underwent port placement by interventional radiologists between October 2004 and January 2018. The 30-day infection rate was compared between inpatients and outpatients using survival analysis. Among inpatients, the effect of time from admission to port placement and from placement to discharge was analyzed using a survival regression tree.

RESULTS

The 30-day infection rate was 3.6% (95% confidence interval [CI] = 1.9%-6.1%) among 386 inpatients and 1.0% (95% CI = 0.7%-1.3%) among 4,915 outpatients (hazard ratio [HR] = 3.6, 95% CI = 2.0-6.6, P < .001). Inpatient placement was a significant risk factor after accounting for covariates in multivariate analysis (HR = 2.2, 95% CI = 1.0-4.7, P = .05) and controlling for demographic differences by propensity score matching (HR = 2.8, 95% CI = 1.0-7.8, P = .04). Infection rate was 11% (95% CI = 4.7%-22%) among 65 inpatients in whom time from admission to placement was ≥ 7 days, 5.1% (95% CI = 1.9%-11%) among 129 inpatients in whom admission to placement was < 7 days and time to discharge was > 3 days, and 0% (95% CI = 0%-2.1%) among 192 inpatients in whom admission to placement was < 7 days and time to discharge was ≤ 3 days (P < .001).

CONCLUSIONS

Inpatient port placement was associated with a higher risk of early infection. However, a clinical decision tree based on shorter length of stay before and after placement may identify a subset of hospitalized patients not at increased risk for infection.

摘要

目的

比较住院患者与门诊患者植入完全可植入式中心静脉端口导管后早期感染率,并确定与住院植入相关的风险是否受住院时间长短的影响。

材料与方法

在这项单机构回顾性研究中,2004年10月至2018年1月间,5301例患者(3618例女性;平均年龄57岁)接受了介入放射科医生进行的端口植入。使用生存分析比较住院患者和门诊患者的30天感染率。在住院患者中,使用生存回归树分析从入院到端口植入以及从植入到出院的时间的影响。

结果

386例住院患者的30天感染率为3.6%(95%置信区间[CI]=1.9%-6.1%),4915例门诊患者的感染率为1.0%(95%CI=0.7%-1.3%)(风险比[HR]=3.6,95%CI=2.0-6.6,P<.001)。在多变量分析中考虑协变量并通过倾向得分匹配控制人口统计学差异后,住院植入是一个显著的风险因素(HR=2.2,95%CI=1.0-4.7,P=.05)(HR=2.8,95%CI=1.0-7.8,P=.04)。从入院到植入时间≥7天的65例住院患者中,感染率为11%(95%CI=4.7%-22%),入院到植入时间<7天且出院时间>3天的129例住院患者中,感染率为5.1%(95%CI=1.9%-11%),入院到植入时间<7天且出院时间≤3天的192例住院患者中,感染率为0%(95%CI=0%-2.1%)(P<.001)。

结论

住院患者植入端口与早期感染风险较高相关。然而,基于植入前后较短住院时间的临床决策树可能识别出感染风险未增加的住院患者亚组。

相似文献

1
Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement.住院期间接受中心静脉置管的患者,住院时间可预测早期感染风险。
J Vasc Interv Radiol. 2020 Mar;31(3):454-461. doi: 10.1016/j.jvir.2019.10.017. Epub 2020 Jan 29.
2
Risk Factors for Early Port Infections in Adult Oncologic Patients.成年肿瘤患者早期端口感染的危险因素
J Vasc Interv Radiol. 2020 Sep;31(9):1427-1436. doi: 10.1016/j.jvir.2020.05.018. Epub 2020 Aug 11.
3
Clinical Predictors of Port Infections in Adult Patients with Hematologic Malignancies.血液系统恶性肿瘤成年患者门静脉感染的临床预测因素
J Vasc Interv Radiol. 2018 Aug;29(8):1148-1155. doi: 10.1016/j.jvir.2018.04.014. Epub 2018 Jun 28.
4
Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement.与住院时放置相比,门诊放置皮下静脉接入端口可降低感染和裂开的发生率。
J Vasc Interv Radiol. 2013 Jun;24(6):849-54. doi: 10.1016/j.jvir.2013.02.012. Epub 2013 Apr 10.
5
Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.完全植入式静脉输液港置管感染的危险因素及抗生素预防的作用:倾向评分匹配。
Cardiovasc Intervent Radiol. 2019 Sep;42(9):1302-1310. doi: 10.1007/s00270-019-02255-0. Epub 2019 Jun 11.
6
Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.在三级儿科中心植入皮下胸部端口时出现严重中性粒细胞减少并非端口移除的危险因素。
J Vasc Interv Radiol. 2017 Mar;28(3):398-402. doi: 10.1016/j.jvir.2016.10.007. Epub 2016 Dec 26.
7
Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.儿童重度血友病患者的植入式静脉通路装置:三级儿科机构经验。
Pediatr Radiol. 2020 Jul;50(8):1148-1155. doi: 10.1007/s00247-020-04668-3. Epub 2020 May 11.
8
Evaluation of PICC complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy.骨科骨感染住院患者长期静脉应用抗生素治疗中经外周静脉穿刺中心静脉置管并发症的评估
J Vasc Access. 2015 Jul-Aug;16(4):299-308. doi: 10.5301/jva.5000389. Epub 2015 Apr 27.
9
A comparison of infections and complications in central venous catheters in adults with solid tumours.实体瘤成年患者中心静脉导管感染与并发症的比较
J Vasc Access. 2015 Jan-Feb;16(1):38-41. doi: 10.5301/jva.5000300. Epub 2014 Sep 1.
10
The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?抗生素在预防完全植入式静脉通路装置(TIVAD)感染中的作用;是否存在受益人群?
Clin Imaging. 2018 Sep-Oct;51:213-216. doi: 10.1016/j.clinimag.2018.05.012. Epub 2018 May 28.

引用本文的文献

1
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
2
Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study.通过植入式静脉通路端口接受化疗的癌症患者中心静脉导管相关血流感染的预测因素:一项回顾性观察研究。
Transl Cancer Res. 2023 Dec 31;12(12):3538-3546. doi: 10.21037/tcr-23-1217. Epub 2023 Dec 5.